The Strategy of wound and
infection control in Diabetic
foot ulcer
Haryo Aribowo
Dept Bedah FK UGM/SMF Bedah RSUP Dr. Sarjito
Yogyakarta
Problems
Healing
Infection
Replace
Lose
footwear
footwear
Off-
loading
Amputation
Wound
General epidemiology
252 million diabetics worldwide
Foot problems account for largest number of
hospital bed days
1-4% develop foot ulcer annually, 25% in
lifetime
45-75% of all lower extremity amputations
85% of these preceded by foot ulcer
Two-thirds of elderly patients undergoing
amputation
Studies have shown less costs for saving a
limb cf. amputation
Pathophysiology:
Neuropathy
Motor Sensory Autonomic
Abnormal foot Loss of protective Reduced skin
biomechanics sensation compliance and
lubrication
Ulceration
Vascular
insufficiency Infection
Overview of Diabetic Foot Infections
7% of Population
Diabetic
15-25% Develop Foot Ulcer
40-80% Infected
(or suspected)
40% Mild 30-40% Moderate 20-30% Severe
Microbial complexity
Microbial burden
Clinical risk
Anaerobes
Aerobic Gram-negative rods
Gram positive cocci
Severity
1 2 3 4 Depth
Necrosis
Prior Rx
Treatment: myths
Treat uninfected ulcers to promote healing
Treat infected ulcers until the ulcer is healed
Treat all the organisms isolated from the
microbiological specimens
Hospitalise all infections
Give lots of intravenous therapy
Management of Diabetic foot ulcer
Glucoses control
Nutrition
Debridement/wound care
Infections control
DEBRIDEMENT
1. Surgical : Anaestetic and non anaestetic
Sharp debridement
2. Non surgical : biological agent and non
biological agent
Larva, enzyme, modern dressing
1. Autolitik : aktivasi enzim autolitik tubuh dg
meningkatkan kelembaban jaringan luka,
dg produk seperti hirogel, hidrokoloid.
2. Enzimatik: produk enzim luar.
3. Biological: dg larva lalat emas, atau
keong hitam.
4. Mechanical Gauze Debridement: dresing luka
yg sesuai.
Evaluating the Patient with a DFI
Patient
Systemic response : Fever, chills, sweats
Metabolic status : Hyperglycaemia,
electrolyte imbalance, hyperosmolality, renal
impairment
Cognitive function
Delirium, depression, dementia,
psychosis
Social situation
Support, self-neglect
· Limb/Foot
· Wound
Patient
Limb or Foot
Biomechanics
Vascular
Ischaemia
Venous insufficiency
Neuropathy
Infection
Wound
Size, depth
Necrosis, gangrene
Infection
Clinical Classification of Diabetic Foot Infection
Wound without purulence or other
evidence of inflammation
More than 2 of purulence,
erythema, pain, tenderness,
warmth or induration. Any
cellulitis/erythema extends ≤2 cm
around ulcer and infection is
limited to skin/superficial subcut
tissues. No local complications or
systemic illness
Infection in patient who is systemically well &
metabolically stable but has any of:
cellulitis extending >2 cm; lymphangitis;
spread beneath fascia; deep tissue
abscess; gangrene; muscle, tendon, joint
or bone involved
Infection in a patient with systemic toxicity
or metabolic instability
Outcomes DFI Severity Classification
100%
89%
90%
80%
70%
60%
54%
50%
40%
30%
20%
10%
10% 6%
0%
None
No infection Mild
Mild Moderate
Moderate Severe
Severe
Antibiotic
Agent(s) Mild Moderate Severe
Advised Route Oral for Most Oral or IV Parenteral
Dicloxacillin Yes
Clindamycin Yes
Cephalexin Yes
TMP/SMX Yes Yes
Amoxicillin/clavulanate Yes Yes
Levofloxacin Yes Yes
Cefoxitin Yes
Ceftriaxone Yes
Ampicillin/sulbactam Yes
Linezolid (± aztreonam) Yes
Daptomycin (± aztreonam) Yes
Ertapenem Yes
Cefuroxime (± metronidazole) Yes
Ticarcillin/clavulanate Yes
Piperacillin/tazobactam Yes Yes
Levo- or Cipro- floxacin + Clindamycin Yes Yes
Imipenem-cilastatin Yes
Vanco + Ceftazidime ± metronidazole Yes
TERIMA KASIH